DEFA14A: Foghorn Therapeutics Inc. Announces Annual Meeting of Stockholders

Foghorn Therapeutics Inc. will hold its annual meeting of stockholders on June 17, 2025, to elect directors and ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm.

Summary

• Foghorn Therapeutics Inc. will hold its annual meeting of stockholders on Tuesday, June 17, 2025, at 9:00 AM Eastern Time.
• The meeting will be held live via the internet, and stockholders can register and participate at www.proxydocs.com/FHTX.
• The agenda includes the election of four Class II directors (Stuart Duty, Neil J. Gallagher, M.D., PH.D., Adrian Gottschalk, and Ian F. Smith) each for a three-year term.
• Stockholders will also vote to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The board of directors recommends a vote FOR proposals 1 and 2.
• Stockholders can request a paper or e-mail copy of the proxy materials free of charge, but requests must be made on or before June 6, 2025, to receive them in time for the meeting.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an annual meeting, which is generally neutral. The board's recommendations suggest a degree of confidence in the proposed actions.

Positives

• The company is holding its annual meeting, allowing stockholders to participate in key decisions.
• Stockholders have the option to attend the meeting virtually.
• The board recommends voting in favor of the proposals.

Future Outlook

The meeting will address the election of directors and the ratification of the company's independent auditor, which are standard corporate governance procedures.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to fulfill their corporate governance obligations.

Stakeholder Impact

• Shareholders have the opportunity to vote on key company matters.
• The outcome of the votes will influence the company's governance and financial oversight.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will proceed with the annual meeting on June 17, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Directors, Deloitte & Touche, Voting, Foghorn Therapeutics